RQ-02

N/A

Report date: 2023/12/07 11:32:07
NME

Base Information

Drug NameRQ-02
Drug Alias NameRQ-02
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionViral fusion proteins inhibitors
TargetsViral fusion proteins
Therapy Area/IndicationsRespiratory Syncytial Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRed Queen Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesRed Queen Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsRespiratory Syncytial Virus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A